Actively Recruiting
National Network Genomic Medicine Lung Cancer, Germany
Led by Prof. Dr. Juergen Wolf · Updated on 2023-07-06
30000
Participants Needed
1
Research Sites
665 weeks
Total Duration
On this page
Sponsors
P
Prof. Dr. Juergen Wolf
Lead Sponsor
C
Charite University, Berlin, Germany
Collaborating Sponsor
AI-Summary
What this Trial Is About
Registry of the national Network Genomic Medicine Lung Cancer (nNGM), linking data on molecular diagnostics, clinical characteristics, treatment patterns and outcomes of subjects with non-small cell lung cancer (NSCLC) from 23 specialized cancer centres and more than 400 general hospitals and oncological practices in Germany
CONDITIONS
Official Title
National Network Genomic Medicine Lung Cancer, Germany
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �38 18 years
- Histologically confirmed, locally advanced or metastatic NSCLC (Union for International Cancer Control [UICC] stage IIIb/IV; non-resectable NSCLC)
- From 07/2023: histologically confirmed NSCLC stage Ib, II, III (UICC)
You will not qualify if you...
- Missing written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Cologne
Cologne, Germany
Actively Recruiting
Research Team
A
Anna Rasokat
CONTACT
N
nNGM Geschäftsstelle
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here